Search for: "Dell Products L.P." Results 1 - 18 of 18
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
15 Feb 2011, 9:37 am by Beth Graham
Tex., February 9, 2011), Incompass IT, Inc., a reseller of Dell Marketing, L.P. products, purchased items from Dell totaling more than $75,000 and allegedly failed to pay for the products. [read post]
13 Jul 2011, 3:24 pm by Eric Schweibenz
In the complaint, Intellectual Ventures states that the Proposed Respondents import and sell products that infringe the asserted patents. [read post]
3 Sep 2011, 9:20 pm by Alex Gasser
International Trade Commission issued a press release announcing that it voted to institute an investigation of Certain Dynamic Random Access Memory and NAND Flash Memory Devices and Products Containing Same (Inv. [read post]
12 May 2010, 7:19 am by Sheppard Mullin
Dell Marketing, L.P., et al., No. 06-10546-PBS (April 27, 2010), the Massachusetts district court dismissed plaintiff Christopher Crennen’s False Claim Act lawsuit against 10 GSA Schedule contractors. [read post]
13 Oct 2010, 12:00 pm by Stefanie Levine
”[13]  Recent decisions have altered this standard, making it more difficult for patentees to base the damages award on the entire price of the product when the patented invention is but a small portion of the product. [read post]
4 Apr 2010, 1:39 pm
Dell, Inc., 519 F.3d 1366, 1375 (Fed. [read post]
15 Jan 2008, 3:06 am
filed 04/18/07 1:07-cv-02178 Vanguard Products Group, Inc. et al v. [read post]
6 Jan 2019, 8:24 pm by Omar Ha-Redeye
This principle was described by the Supreme Court of Canada in Dell Computer Corp. v. [read post]
23 Jan 2015, 9:30 am
Bloomberg, L.P., 2014 WL 1044027, at *3 (S.D.N.Y. [read post]
22 Feb 2008, 6:00 pm
: (Patent Baristas),Vietnam : new developments in patent protection for medical uses: (Patent Docs),Wisconsin Alumni Research Foundation licenses stem cell patents to BioTime: (IPBiz)Pharma & Biotech - ProductsFloxin (Ofloxacin) –US Supreme Court declines Daiichi Sankyo’s request for appeal of CAFC decision reversing Daichii’s initial win in its ofloxacin patent infringement case against Apotex: (IP Law360),Galvus (Vildagliptin) – Indian patent granted… [read post]